5-(2-乙氧基苯基)-1,3,4-噁二唑-2-硫醇 | 19982-38-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 5-(2-乙氧基苯基)-1,3,4-噁二唑-2-硫醇
• 英文名称: 2-(o.etossifenil)-5-mercapto-1,3,4-oxadiazolo
• 英文别名: 2-Mercapto-5-(2-ethoxyphenyl)-1,3,4-oxadiazol；5-(2-ethoxy-phenyl)-3H-[1,3,4]oxadiazole-2-thione；5-(2-Ethoxyphenyl)-1,3,4-oxadiazole-2-thiol；5-(2-ethoxyphenyl)-3H-1,3,4-oxadiazole-2-thione
• CAS: 19982-38-8
• 化学式: C₁₀H₁₀N₂O₂S
• mdl: MFCD06629467
• 分子量: 222.268
• InChiKey: VTXLLACKNPVAJW-UHFFFAOYSA-N

物化性质

• 熔点：
  195-197 °C
• 沸点：
  314.4±44.0 °C(Predicted)
• 密度：
  1.33±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  74.9
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 海关编码：
  2934999090

反应信息

• 作为反应物：
  描述：

  5-(2-乙氧基苯基)-1,3,4-噁二唑-2-硫醇 在 sodium hydroxide 、 sodium ethanolate 作用下， 以 乙醇 、 水 为溶剂， 生成 [5-(2-ethoxy-phenyl)-[1,3,4]oxadiazol-2-ylsulfanyl]-acetic acid
  参考文献：
  名称：

  Russo; Ghelardoni, Bollettino Chimico Farmaceutico, 1967, vol. 106, # 12, p. 826 - 836

  摘要：

  DOI：
• 作为产物：
  描述：

  2-乙氧基苯甲酸 在 盐酸 、 硫酸 、 一水合肼 、 potassium hydroxide 作用下， 以 甲醇 、 乙醇 、 水 为溶剂， 生成 5-(2-乙氧基苯基)-1,3,4-噁二唑-2-硫醇
  参考文献：
  名称：

  Ultrasound-assisted, one-pot, three-component synthesis and antibacterial activities of novel indole derivatives containing 1,3,4-oxadiazole and 1,2,4-triazole moieties

  摘要：

  摘要 通过超声辐照，以4-氨基-5-(1H-吲哚-3-基)-4H-[1,2,4]三唑-3-硫醇(8)和2-巯基-5-取代的-1,3,4-噁二唑(5a–m)为原料，高效合成了十三种新型吲哚衍生物。与传统方法和微波方法相比，产率提高到82–93%，反应时间缩短到15–35分钟。这些新化合物的结构通过光谱数据和元素分析得到表征。合成的化合物中有两种(10f和10l)对金黄色葡萄球菌和大肠杆菌显示出优异的活性，因此值得进一步研究。 补充材料： 本文的补充材料以单独文件形式提供：mmc1.pdf

  DOI：

  10.1016/j.crci.2015.09.005

文献信息

• Synthesis, molecular modeling and biological evaluation of 2-(benzylthio)-5-aryloxadiazole derivatives as anti-tumor agents
  作者：Kai Liu、Xiang Lu、Hong-Jia Zhang、Juan Sun、Hai-Liang Zhu

  DOI：10.1016/j.ejmech.2011.11.015

  日期：2012.1

  A series of 2-(benzylthio)-5-aryloxadiazole derivatives have been designed and synthesized, and their biological activities are also evaluated for EGFR inhibitory activity. Fourteen compounds among the twenty compounds are reported for the first time. Their chemical structures are characterized by 1H NMR, MS, and elemental analysis. Anti-proliferative and EGFR inhibition assay results have demonstrated

  已经设计和合成了一系列2-（苄硫基）-5-芳基恶二唑衍生物，并且还评估了它们的生物活性对EGFR的抑制活性。首次报道了二十种化合物中的十四种化合物。它们的化学结构通过1 H NMR，MS和元素分析进行表征。抗增殖和EGFR抑制测定的结果已经证实，化合物3e中示出了最有效的生物活性（IC 50  = 1.09μM为MCF-7和IC 50  = 1.51μM为EGFR）。已执行对接仿真以定位化合物3e进入EGFR活性位点以确定可能的结合模型，估计结合自由能值为-10.7 kcal / mol。在肿瘤生长抑制中具有有效抑制活性的化合物3e可能是有前途的抗肿瘤主导化合物，值得进一步研究。
• Synthesis, biological evaluation and molecular docking studies of novel 2-(1,3,4-oxadiazol-2-ylthio)-1-phenylethanone derivatives
  作者：Li-Rong Zhang、Zhi-Jun Liu、Hui Zhang、Jian Sun、Yin Luo、Ting-Ting Zhao、Hai-Bin Gong、Hai-Liang Zhu

  DOI：10.1016/j.bmc.2012.03.061

  日期：2012.6

  In present study, a series of new 2-(1,3,4-oxadiazol-2-ylthio)-1-phenylethanone derivatives (6a–6x) as potential focal adhesion kinase (FAK) inhibitors were synthesized. The bioassay assays demonstrated that compound 6i showed the most potent activity, which inhibited the growth of MCF-7 and A431 cell lines with IC50 values of 140 ± 10 nM and 10 ± 1 nM, respectively. Compound 6i also exhibited significant

  在本研究中，合成了一系列新型的2-（1,3,4-恶二唑-2-基硫基）-1-苯基乙酮衍生物（6a - 6x）作为潜在的粘着斑激酶（FAK）抑制剂。生物测定表明，化合物6i表现出最强的活性，抑制了MCF-7和A431细胞系的生长，IC 50值分别为140±10 nM和10±1 nM。化合物6i还表现出显着的FAK抑制活性（IC 50  = 20±1 nM）。进行对接模拟以将化合物6i定位在FAK的活性位点中，以确定可能的结合模型。
• Bromide‐Catalyzed Electrochemical C <i>sp</i> ³ −H Oxidation of Acetonitrile: Stereoselective Synthesis of Heteroaryl Vinyl Sulfides
  作者：Jin‐Lin Wan、Jing‐Mei Huang

  DOI：10.1002/adsc.202200247

  日期：2022.8.2

  An electrochemical oxidative C−H/S−H cross-coupling reaction between acetonitrile and heteroaryl thiols has been developed. Me4NBr is employed as a redox catalyst to oxidize both the Csp3−H of acetonitrile and S−H of heteroaryl thiols. Heteroaryl vinyl sulfides were afforded under metal-free and oxidant-free reaction conditions in good yields and stereoselectivities with excellent functional group

  已经开发了乙腈和杂芳基硫醇之间的电化学氧化 C-H/S-H 交叉偶联反应。Me 4 NBr 用作氧化还原催化剂以氧化乙腈的 C sp 3 -H 和杂芳基硫醇的 S-H。在无金属和无氧化剂的反应条件下，杂芳基乙烯基硫化物具有良好的收率和立体选择性，具有优异的官能团耐受性。电化学方法的合成适用性因其易于扩展而进一步突出。
• Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety as potential antitumor agents
  作者：Qing-Zhong Zheng、Xiao-Min Zhang、Ying Xu、Kui Cheng、Qing-Cai Jiao、Hai-Liang Zhu

  DOI：10.1016/j.bmc.2010.09.051

  日期：2010.11.15

  A series of new 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety were synthesized. Anti-proliferative assay results indicated that compounds 6o and 6u exhibited the most potent activity against gastric cancer cell SGC-7901, which was more potent than the positive control. Especially, compound 6o exhibited significant telomerase inhibitory activity (IC50 = 2.3 +/- 0.07 mu M), which was comparable to the positive control ethidium bromide. Docking simulation was performed to position compound 6o into the active site of telomerase (3DU6) to determine the probable binding model. (C) 2010 Elsevier Ltd. All rights reserved.
• Novel 1,3,4-oxadiazole thioether derivatives targeting thymidylate synthase as dual anticancer/antimicrobial agents
  作者：Qian-Ru Du、Dong-Dong Li、Ya-Zhou Pi、Jing-Ran Li、Jian Sun、Fei Fang、Wei-Qing Zhong、Hai-Bin Gong、Hai-Liang Zhu

  DOI：10.1016/j.bmc.2013.02.008

  日期：2013.4

  A series of novel 1,3,4-oxadiazole thioether derivatives (compounds 9-44) were designed and synthesized as potential inhibitors of thymidylate synthase (TS) and as anticancer agents. The in vitro anticancer activities of these compounds were evaluated against three cancer cell lines by the MTT method. Among all the designed compounds, compound 18 bearing a nitro substituent exhibited more potent in vitro anticancer activities with IC50 values of 0.7 +/- 0.2, 30.0 +/- 1.2, 18.3 +/- 1.4 mu M, respectively, which was superior to the positive control. In the further study, it was identified as the most potent inhibitor against two kinds of TS protein (for human TS and Escherichia coli TS, IC50 values: 0.62 and 0.47 mu M, respectively) in the TS inhibition assay in vitro and the most potent antibacterial agents with MIC (minimum inhibitory concentrations) of 1.56-3.13 mu g/mL against the tested four bacterial strains. Molecular docking and 3D-QSAR study supported that compound 18 can be selected as dual antitumor/antibacterial candidate in the future study. (C) 2013 Elsevier Ltd. All rights reserved.